Cardioprotection Conferred by Sitagliptin Is Associated with Reduced Cardiac Angiotensin II/Angiotensin-(1-7) Balance in Experimental Chronic Kidney Disease. [electronic resource]
Producer: 20190812ISSN:- 1422-0067
- Angiotensin I -- blood
- Angiotensin II -- blood
- Animals
- Anti-Inflammatory Agents -- pharmacology
- Antioxidants -- pharmacology
- Blood Pressure -- drug effects
- Body Weight -- drug effects
- Cardiotonic Agents -- pharmacology
- Diastole -- drug effects
- Dipeptidyl Peptidase 4 -- metabolism
- Dipeptidyl-Peptidase IV Inhibitors -- pharmacology
- Kidney -- drug effects
- Kidney Function Tests
- Male
- Myocardium -- metabolism
- Peptide Fragments -- blood
- Peptidyl-Dipeptidase A -- metabolism
- Rats, Wistar
- Renal Insufficiency, Chronic -- blood
- Renin-Angiotensin System -- drug effects
- Sitagliptin Phosphate -- pharmacology
- Up-Regulation -- drug effects
- Ventricular Remodeling -- drug effects
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.